For All The Latest Medical News, Health News, Research News, COVID-19 News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Cardiology News, Epigenetic News, Cancer News, Doctor News, Hospital News

BREAKING NEWS

Cancer

Keeping you updated with all the latest developments, researches, drug trials and treatment protocols for cancer. For detailed information about cancer including cancer types, cancer treatments, cancer drugs, cancer care and also the best cancer hospitals and cancer doctors in Thailand, please visit our other website: www.thailandcancerhelp.com
Source: Cancer Drugs  Dec 18, 2020  4 years ago
Cancer Drugs: Pembrolizumab, an immunotherapy drug has been recently approved by the U.S. FDA  as a first-line treatment for patients with certain types of advanced colorectal cancer. This is the 9th FDA approval supported by Stand Up To Cancer® (SU2C) research. Individuals newly diagnosed with advanced or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (d...
Source: Cancer Herbs  Dec 15, 2020  4 years ago
Cancer-Herbs: Researchers from the Translational Genomics Research Institute-Phoenix (an affiliate of City of Hope), Baylor Institute for Immunology Research-Dallas and the Salk Institute for Biological Studies-San Diego have in a new study found that a phytochemical derived from the Tripterygium Wilfordii Plant (Commonly called thunder god vine) is able to kill cancer cells and potentially improv...
Source: Perelman School of Medicine at the University of Pennsylvania  Dec 07, 2020  4 years ago
Cancer News: According to new preclinical data from oncologists and researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center, knocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology enhanced the engineered T cells' ability to eliminate blood cancers.   The new study findings ...
Source: COVID-19 And Cancer  Oct 03, 2020  4 years ago
COVID-19-Cancer: A new study by researchers from The University of Arkansas for Medical Sciences (UAMS) have shown that SARS-CoV-2 encoded proteins along with certain drugs currently used in COVID-19 treatment protocols are able to induce lytic reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV), one of major human oncogenic viruses through manipulation of intracellular signaling ...
Source: Nutrition And Diets  Sep 29, 2020  4 years ago
Nutrition And Diets: Researchers from University of Gothenburg-Sweden, Lund University-Sweden and the University of South Australia in a preclinical study found that dietary oat bran can offset chronic gastrointestinal damage caused by radiotherapy, contradicting long-held clinical recommendations.   The goal of this study was to evaluate the influence of dietary fiber on radiation-ind...
Source: Pancreatic Cancer  Sep 15, 2020  4 years ago
Pancreatic Cancer: Oncologist and genomic scientists led by Mayo Clinic and the Translational Genomics Research Institute (TGen),along with teams from University of California-San Diego,  Sloan Kettering Institute, Salk Institute for Biological Studies and  University of Nebraska in a new study have  identified specific potential therapeutic targets for the most aggressive and letha...
Source: Ovarian Cancer  Sep 12, 2020  4 years ago
Ovarian Cancer:  Researchers from Finland have developed a new quantitative lateral flow immunoassay (LFIA) of aberrantly glycosylated CA125 which is widely superior to the conventional CA125 immunoassay (CA125IA).  The new diagnostic was also faster and much more accurate than current conventional CA125 test.   With a 30 min read-out time, the LFIA showed 72% sensitiv...
Source: Cancer And Hair Dyes  Sep 03, 2020  4 years ago
A cohort study by researchers from Harvard Medical School on women in the United States who use permanent hair dye products to color their hair at home has found that most do not experience greater risk of most cancers or greater cancer related mortality.   The study findings were published in the British Medical Journal. https://www.bmj.com/content/370/bmj.m2942   Although the study f...
Source: Pancreatic Cancer  Aug 26, 2020  4 years ago
Pancreatic Cancer: One of the most difficult cancers to treat and one that has a high mortality rate is pancreatic cancer. One of the reasons is for is that   pancreatic cancer is rarely detected at its early stages because symptoms often do not present themselves until after the cancer has progressed. Very often by the time the cancer is detected, invasive procedures such as surgery, ch...
Source: Skin Cancer  Aug 08, 2020  4 years ago
Skin Cancer: A novel immunotherapy protocol involving adoptive T cell transfer combined with dendritic cell vaccination for the skin cancer malignant melanoma shows promising results.   The clinical research involving three severely ill patients who are now long-term survivors has given optimism for others in a similar predicament.   The research published in the journal: OncoImmunolog...
Source: ASCO  Jul 28, 2020  4 years ago
ASCO: The American Society of Clinical Oncology, Inc. (ASCO®) is proud to announce the appointment of Dr Jonathan W. Friedberg, MD, MMSc, as the next editor-in-chief of the Journal of Clinical Oncology (JCO), the flagship journal of the American Society of Clinical Oncology (ASCO).  Dr Jonathan W. Friedberg, MD, MMSc Credit:University of Rochester Medical Center The Journal o...
Source: Thailand Medical News  Jul 22, 2020  4 years ago
Brain Cancer: Medical researchers affiliated with the University of São Paulo's Ribeirão Preto Medical School (FMRP-USP) in Brazil have demonstrated the potential of a leukemia drug, arsenic trioxide, to treat medulloblastoma, a type of brain cancer most common in children. When they tested arsenic trioxide on cells taken from one of the most aggressive subgroups of this type of ...
Source: Cancer Treatments  Jul 12, 2020  4 years ago
Cancer Treatments: Oncology researchers from Stanford University and Washington State University have demonstrated that a fatty acid called dihomogamma-linolenic acid, or DGLA, can be used to target and kill human cancer cells.   The research findings published in the journal: Developmental Cell, found that DGLA can induce ferroptosis in an animal model and in actual human cancer cells...
Source: Prostate Cancer  Jun 28, 2020  4 years ago
Prostate Cancer: A international collaborative study led by researchers from Carolina Urologic Research Center-South Carolina and involving  more than 15 medical entities from around the world spanning Tokyo, France, Canada etc, has demonstrated that the use of oral relugolix in men with prostate cancer may help to achieve rapid, sustained suppression of testosterone levels as compared to inj...
Source: Liver Cancer  Jun 27, 2020  4 years ago
Liver Cancer: Researchers from Sanford Burnham Prebys Medical Institute and Weill Cornell School Of Medical Sciences at Cornell University have  discovered an enzyme that blocks metabolic processes and contribute to the rapid growth and spread of liver cancer.   The research findings, published in Cancer Cell, could spur development of new therapies for a type of cancer that has b...
Source: Breast Cancer  Jun 26, 2020  4 years ago
Breast Cancer: A new study by researchers from San Diego State University has found that cancer survivors have a reduced capacity to process highly acidic foods and such foods can actually increase the risk of recurrence or even mortality. Foods such as fresh and processed meats, cheese, eggs, sugary food, soft drinks, and grains are acid-producing foods and they produce sulfuric, phosphoric, or o...
Source: Lung Cancer  Jun 24, 2020  4 years ago
Lung Cancer: A new study by Swiss researches show that blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer as it could help slow the growth of tumors.   It is a well-known fact that cancer cells use a lot of sugar to fuel their rapid growth and spread.   Hence this has led scientists to consider cutting off their sugar supply as a way to tr...
Source: Photodynamic Therapy  Jun 22, 2020  4 years ago
Photodynamic Therapy: Oncology researchers from Kazan Federal University and Medical Center of the Presidential Administration of Kazakhstan have found that Photodynamic therapy is a useful treatment option for metastatic ovarian cancer.   Their research findings was published in the journal: BioNano Science https://link.springer.com/article/10.1007/s12668-020-00749-7   PDT or Photodyn...
Source: Immunotherapy and Vitamin D  Jun 22, 2020  4 years ago
Immunotherapy: Researchers from Harvard Medical School in new study they recently conducted are saying that taking vitamin D supplements may help prevent a potentially serious side effect of a revolutionary form of anti-cancer therapy known as immunotherapy. This is typical side-effect is the inflammation of the colon or colitis. Therapeutically, immune checkpoint inhibitors help the immune ...
Source: Prostate Cancer  Jun 21, 2020  4 years ago
Prostate Cancer:  Pre-clinical trials by the University of South Australia indicate that reformulation of the prostate cancer drug abiraterone acetate improves the drug's effectiveness by 40 per cent and dramatically improve the quality of life for individuals suffering from prostate cancer.   The research findings have been published in the International Journal of Pharmaceutics. ...
Source: Chemotherapy, Doxirubicin And Heart Failure  Jun 20, 2020  4 years ago
Chemotherapy: Medical researchers from Yale have developed a technique to predict whether cancer patients receiving a common chemotherapy drug are likely to experience heart failure as a result.   Doxorubicin, a chemotherapy drug which is often used to treat a number of cancers, including breast and bladder cancers, lymphoma, and Kaposi's sarcoma also has some negative side-effects of w...
Source: Breast Cancer  Jun 18, 2020  4 years ago
Breast Cancer: A new research by oncologists from the University of Notre Dame-Indiana  shows that statins which are drugs used to treat high cholesterol could interfere with the way breast cancer cells adapt to the microenvironment in the brain, preventing the cancer from taking hold. Patients with breast cancer who experience this type of metastasis typically survive for only months after d...
Source : Mesothelioma and Cancer  Jun 15, 2020  5 years ago
Mesothelioma: According to a cancer research abstract presented during a virtual session of the Society of Interventional Radiology's 2020 Annual Scientific Meeting held yesterday by cancer researchers from Moffitt Cancer Center in Florida and also the University of South Florida, a novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients...
Source: Aspirin and Cancer  Jun 13, 2020  5 years ago
Aspirin and Cancer: Oncology and medical researchers have discovered from an international clinical trial that a regular dose of aspirin taken to reduce the risk of inherited bowel cancer can have long lasting effects even up to 10 years after stopping treatment. The clinical trial known as CAPP2 involved patients with Lynch syndrome from around the world and revealed that two aspirins a day, for ...
Source: Aspirin And Cancer  Jun 09, 2020  5 years ago
Aspirin: A detailed meta-analysis by Italian researchers involving more than 113 past cancer studies indicates that by taking one or two aspirin doses a week helps ward off cancer, especially liver, stomach, pancreatic and bowel cancer. However they warned that while taking aspirin reduces the risk of cancer, it can increase the risk of ulcers and stomach bleeding and no one should ever start taki...
Source: Chemotherapy  Jun 03, 2020  5 years ago
Chemotherapy: Medical and oncology researchers from University Of Virginia in a new study found that what a cancer patient eats can affect the outcome of chemotherapy. The same can be applied to other patients with other chronic conditions and the corresponding medical treatments.   The research paper was published in the journal: Nature Communications. https://www.nature.com/articles/s4146...
Source: Immunotherapy  Jun 02, 2020  5 years ago
Immunotherapy: A research led by medical scientists from the Ohio State University Comprehensive Cancer Center has identified a protein called PCBP1 within certain immune cells that is required for optimal immune responses to cancer.   The study findings, reported in the journal Science Advances, also suggest that the protein might be useful for predicting which cancer patients&nb...
Source: ASCO20 Cancer Updates  May 30, 2020  5 years ago
ASCO20 Cancer Updates:  Medical researchers from the University College London (UCL) and University College London Hospitals NHS Foundation Trust (UCLH) in a recent large  international clinical trial have found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of patients with a specific subtype of advanced bowel cancer, when com...
Source: Cancer Diagnostics  May 29, 2020  5 years ago
Cancer Diagnostics: Biotech and medical researchers from the University of Birmingham are developing a new type of diagnostic test that uses complex sugars to detect prostate cancer earlier and with greater accuracy.   The new diagnostic test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo ...
Source: Brain Cancer  May 27, 2020  5 years ago
Brain Cancer: Researchers from Virginia Commonwealth University Massey Cancer Center and Institute of Molecular Medicine (VIMM) have reported that lumefantrine, an FDA-approved drug used to treat malaria has demonstrated effectiveness to enhance existing treatment protocols to treat Glioblastoma multiforme (GBM), an aggressive form of cancer in the brain that is typically fatal.   The resea...
Source: Breast Cancer  May 26, 2020  5 years ago
Breast Cancer: Oncology researchers from University Of South Australia have made a significant breakthrough by discovering how an obscure protein causes breast cancer to develop and grow more quickly.   According to Associate Professor Dr Michael Samuel, a senior University Of South Australia researcher in the Centre for Cancer Biology (CCB), who spearheaded this research with co-lead scien...
Source: Cancer News  May 18, 2020  5 years ago
Cancer:  Medical and oncology researchers from the University of Eastern Finland have developed a new and promising pharmaceutical compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells. Since amino acids are critical for the growth and division of cancer cells, the new LAT1 inhibitor makes it possible to inhibit the growth of cancer cells.   ...
Source: Cancer News  May 13, 2020  5 years ago
Cancer News: Medical and oncology researchers from University Of Southern California and the IFOM Cancer Institute in Milan have found that a fasting-mimicking diet could be more effective at treating some types of cancer including colorectal cancers when combined with vitamin C.   In research on animal models, the team found that the combination delayed tumor progression in multiple animal...
Source : Cancer News  May 05, 2020  5 years ago
Cancer: Oncology researchers at the University of Alberta are enhancing a breast cancer therapy by improving how the treatment is delivered.   Dr Hasan Uludag, a Professor in chemical and materials engineering, and his team have developed a chemical compound that allows them to effectively inject genetic material into cells. https://www.liebertpub.com/doi/10.1089/hum....
Source: Covid-19 News  Mar 27, 2020  5 years ago
According to a research letter published online March 25 in JAMA Oncology, patients with cancer in Wuhan had an increased risk for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infections. The journal warns that similar issues could also affect cancer patients elsewhere. (https://jamanetwork.com/journals/jamaoncology/fullarticle/2763673)   Dr Jing Yu, M.D., from the Zhon...
Source: Thailand Medical News  Feb 01, 2020  5 years ago
A new year-by-year age meta-analysis of colorectal cancer rates among U.S. adults and also adults globally finds a 46% increase in new diagnoses from ages 49 to 50, indicating that many latent cases of the disease are likely going undiagnosed until routine screenings begin at 50, according to a new study in JAMA Network Open. Lead study author Dr. Jordan Karlitz, associate clinical professo...
Source: Thailand Medical News  Jan 31, 2020  5 years ago
A new research study by oncology researchers at the University Of California Los Angeles Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumor immune cells, or T cells, may produce a stronger immune response that could help fight advanced melanoma.   The researchers told T...
Source: Thailand Medical News  Jan 29, 2020  5 years ago
Medical and oncology researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, have developed a new ultrasensitive blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is still experimental, was published online in the journal Nature Communications.   The medical inve...
Source: Thailand Medical News  Jan 19, 2020  5 years ago
Medical scientists at the University of Glasgow and Cancer Research UK Beatson Institute have tested close to 1000 existing medicines and discovered that a cheap drug commonly used to treat parasitic worm infection could be a game-changing treatment for prostate cancer. Prostate cancer is the most common cancer affecting men and the second most common cause of cancer death for men globally. &nbs...
Source: Thailand Medical News  Jan 18, 2020  5 years ago
Researchers from New Ohio State University have shown an association between breast cancer survivors' use of proton pump inhibitors (PPIs) and reports of problems with concentration and memory. On average, cognitive problems reported by PPI users were between 20 and 29 percent more severe than issues reported by non-PPI users. PPIs are sold under such brand names as Nexium, Prevacid ...
Source: Thailand Medical News  Dec 26, 2019  5 years ago
A new investigational cancer drug that targets tumors caused by mutations in the KRAS gene will be evaluated in phase 2 clinical trials, following promising safety and efficacy results in preliminary human studies and excellent results in animal studies. The drug, developed by Amgen and currently referred to as AMG 510, is the first therapy to reach clinical trials that inhibits a mutant KRAS prot...
Source: Thailand Medical News  Dec 21, 2019  5 years ago
Prostate Cancer According to a new University College of London-led computer modelling study, nearly one in six deaths from prostate cancer could be prevented if targeted screening was introduced for men at a higher genetic risk of the disease. Prostate cancer is the most common form of cancer in men with around 1.3 million new cases diagnosed globally each year and more than 400,000 men a yea...
Source: Thailand Medical News  Dec 19, 2019  5 years ago
Medical researchers at Children's Medical Center Research Institute at University Of Texas Southwestern (CRI) have uncovered why certain melanoma cells are more likely to spread through the body. The discovery opens up a potential new avenue of treatment and could be used to help reduce the proportion of patients who progress from stage 3 melanoma to more-deadly stage 4 cancer. Dr. Sean Mor...
Source: Thailand Medical News  Dec 15, 2019  5 years ago
Scientists from QIMR Berghofer Medical Research Institute, Brisbane have discovered a potential new cancer immunotherapy target that involves switching off a regulatory cell to stop tumors growing and spreading. The new study findings have been published today in Cancer Discovery, a journal of the American Association for Cancer Research. Associate Professor Dr Michele Teng, senior resear...
Source: Thailand Medical News  Dec 10, 2019  5 years ago
Oncologists who treat patients with the aggressive triple negative breast cancer have two new ways to predict which cancer patients may benefit most from the well-established post-surgery treatment known as AC chemotherapy, short for adjuvant doxorubicin and cyclophosphamide. Oncology researchers from the SWOG Cancer Research Network, a cancer clinical trials network funded by the National Canc...
Source: Thailand Medical News  Dec 05, 2019  5 years ago
Though prostate cancer is the most common cancer in men globally, we still have yet to know all of its causes. The largest ever study to use genetics as a measurement for physical activity to look at its effect on prostate cancer, reveals that being more active reduces the risk of prostate cancer. Over 140,000 men were included in the study, of which, 80,000 had prostate cancer. The study, publ...
Source: Thailand Medical News  Dec 04, 2019  5 years ago
A Phase 11 clinical trial involving a pioneering precision medicine already licensed for breast and ovarian cancer can also slow or stop tumour growth in some men with advanced prostate cancer. The recently concluded phase II trial found that over 80 per cent of men with prostate cancer whose tumours had mutations in the BRCA genes responded well to treatment with the target...
Source: Thailand Medical News  Nov 30, 2019  5 years ago
Researchers from the University Of Buffalo have developed a new, portable breast imaging system that has the potential to better identify breast cancer in women with dense breast tissue. That is among the findings of a study published in the journal IEEE Transactions on Biomedical Engineering . The research study was led by University at Buffalo researchers in collaboration with Roswell...
Source: Thailand Medical News  Nov 30, 2019  5 years ago
Dr. David P. Labbé, a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), and his colleagues were recently able to discover what molecular events occur for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet in an extensive research study. In a study published in Nature Communications, they showed that saturated f...
Source: Thailand Medical News  Nov 28, 2019  5 years ago
Flavonoids which are phytochemicals found in fruits and vegetables, can help prevent colorectal cancer. Though studies conducted during the last 20 years have established this, scientists have struggled to determine how flavonoids are responsible for cancer prevention. Associate professor Jayarama Gunaje, left, and doctoral student Ranjini Sankaranarayanan of the Department of Pharmaceutical Sci...
Source: Thailand Medical News  Nov 28, 2019  5 years ago
Typically, it is a feeling that many who receive a cancer diagnosis can identify with: heartbreak and fear, followed by hopes that chemotherapy will save the day. Unfortunately, for many patients, chemo's painful side effects cause them to stop treatment prematurely. Fortunately, a research team headed by Professor Alexander Binshtok, head of the Pain Plasticity Research Group at the Hebrew U...
Source: Thailand Medical News  Nov 27, 2019  5 years ago
University of Western Ontario are conducting a new clinical study that looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. The multi-center trial registry testing the use of a new imaging tracer ie the prostate specific membrane a...
Source: Thailand Medical News  Nov 27, 2019  5 years ago
A new research by Peter MacCallum Cancer Centre has shed new light on why men are more likely than women to get cancer, uncovering a new role for the X chromosome in affecting cancer risk and mortality. While males are known to have a higher risk of developing, and dying from, cancer compared to women even when matched for other known cancer risk factors like age, race, smoking histor...
Source: Thailand Medical News  Nov 26, 2019  5 years ago
Globally, more than 1,180 individuals are diagnosed with pancreatic cancer each day. Within 12 months of diagnosis, 85% will die from it as its one of the most deadly cancers. Despite being lethal, a new research from the University of South Australia could help vastly improve the prognosis for pancreatic cancer patients. Utilizing  a new targeted radioimmunotherapy agent, UniSA Prof...
Source: Thailand Medical News  Nov 25, 2019  5 years ago
Lynparza or Olaparib, is a pharmacological inhibitor of the enzyme PARP (poly ADP Ribose polymerase or PARP) which is required for cancer cell DNA repair. In the presence of certain mutations like BRCA1 and BRCA2, Olaparib kills cancer cells. Olaparib is typically used to treat women suffering from ovarian and breast cancers, has shown promising results when administered to men in whom pro...

MOST READ

Nov 05, 2024  18 days ago
Nikhil Prasad
Jul 25, 2024  4 months ago
Nikhil Prasad
Jul 24, 2024  4 months ago
Nikhil Prasad
Jun 10, 2023  1 year ago
COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Aug 04, 2022  2 years ago
Source: Medical News - SARS-CoV-2 & Cancer

Interesting Reads

Nikhil Prasad
Oct 21, 2024  1 month ago
Nikhil Prasad
Oct 02, 2024  2 months ago
Nikhil Prasad
Jul 23, 2024  4 months ago
Nikhil Prasad
Jun 22, 2024  5 months ago
COVID-19 News - Head And Neck Cancers - By Nikhil P & Kittisak M
Feb 02, 2023  2 years ago
Source: Nitric Oxide and COVID-19
Jun 15, 2020  5 years ago
Source: COVID-19 Asymptomatic and Presymptomatic
Jun 14, 2020  5 years ago
Source: Myocardial Injury
Jun 09, 2020  5 years ago

FROM THAILAND MEDICAL

LATEST ON ARTHRITIS